Literature DB >> 26017163

Drug Carriers: Not an Innocent Delivery Man.

Yoon Yeo1, Bieong-Kil Kim.   

Abstract

Biomaterials used as drug carriers are often considered inactive and assumed to have no other roles than modifying pharmacokinetics and biodistribution of a drug. On the other hand, there are several examples in which the carrier materials show bioactivities in the body, which may have been underestimated or inadvertently ignored. This review highlights several examples where biomaterials used as drug carriers bring biological effects, known or newly discovered, and discusses their implications in development of new drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26017163      PMCID: PMC4540736          DOI: 10.1208/s12248-015-9789-6

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  86 in total

Review 1.  Biochemistry, histology and clinical uses of chitins and chitosans in wound healing.

Authors:  R A Muzzarelli; M Mattioli-Belmonte; A Pugnaloni; G Biagini
Journal:  EXS       Date:  1999

2.  Membrane cartridges for endotoxin removal from interferon preparations.

Authors:  Jinghua Li; Yingguang Shao; Zhaoan Chen; Runzi Cong; Junde Wang; Xueliang Liu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-07-05       Impact factor: 3.205

Review 3.  Chitosan chemistry and pharmaceutical perspectives.

Authors:  M N V Ravi Kumar; R A A Muzzarelli; C Muzzarelli; H Sashiwa; A J Domb
Journal:  Chem Rev       Date:  2004-12       Impact factor: 60.622

Review 4.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

Review 5.  The structure and function of hyaluronan: An overview.

Authors:  T C Laurent; U B Laurent; J R Fraser
Journal:  Immunol Cell Biol       Date:  1996-04       Impact factor: 5.126

6.  Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.

Authors:  E T Dams; P Laverman; W J Oyen; G Storm; G L Scherphof; J W van Der Meer; F H Corstens; O C Boerman
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

7.  Novel non-acidic formulations of haloperidol complexed with beta-cyclodextrin derivatives.

Authors:  Y L Loukas; V Vraka; G Gregoriadis
Journal:  J Pharm Biomed Anal       Date:  1997-10       Impact factor: 3.935

8.  Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts.

Authors:  Ilaria De Stefano; Alessandra Battaglia; Gian Franco Zannoni; Maria Grazia Prisco; Andrea Fattorossi; Daniele Travaglia; Silvia Baroni; Davide Renier; Giovanni Scambia; Cristiano Ferlini; Daniela Gallo
Journal:  Cancer Chemother Pharmacol       Date:  2010-09-17       Impact factor: 3.333

9.  Choice of cyclodextrin for cellular cholesterol depletion for vascular endothelial cell lipid raft studies: cell membrane alterations, cytoskeletal reorganization and cytotoxicity.

Authors:  Adam H Hinzey; Michelle A Kline; Sainath R Kotha; Sean M Sliman; Elizabeth S O'Connor Butler; Andrew B Shelton; Travis R Gurney; Narasimham L Parinandi
Journal:  Indian J Biochem Biophys       Date:  2012-10       Impact factor: 1.918

10.  Drug-free macromolecular therapeutics: induction of apoptosis by coiled-coil-mediated cross-linking of antigens on the cell surface.

Authors:  Kuangshi Wu; Jihua Liu; Russell N Johnson; Jiyuan Yang; Jindrich Kopecek
Journal:  Angew Chem Int Ed Engl       Date:  2010-02-15       Impact factor: 15.336

View more
  6 in total

1.  Development of Liposomal Gemcitabine with High Drug Loading Capacity.

Authors:  Hassan Tamam; Jinho Park; Hytham H Gadalla; Andrea R Masters; Jelan A Abdel-Aleem; Sayed I Abdelrahman; Aly A Abdelrahman; L Tiffany Lyle; Yoon Yeo
Journal:  Mol Pharm       Date:  2019-06-14       Impact factor: 4.939

2.  Albumin-coated nanocrystals for carrier-free delivery of paclitaxel.

Authors:  Joonyoung Park; Bo Sun; Yoon Yeo
Journal:  J Control Release       Date:  2016-12-31       Impact factor: 9.776

Review 3.  Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy.

Authors:  Fanfei Meng; Ning Han; Yoon Yeo
Journal:  Expert Opin Drug Deliv       Date:  2016-08-08       Impact factor: 6.648

Review 4.  Nucleic acid and oligonucleotide delivery for activating innate immunity in cancer immunotherapy.

Authors:  Fanfei Meng; Jianping Wang; Yoon Yeo
Journal:  J Control Release       Date:  2022-03-26       Impact factor: 11.467

5.  Polyethylenimine-dermatan sulfate complex, a bioactive biomaterial with unique toxicity to CD146-positive cancer cells.

Authors:  Bieong-Kil Kim; Dongkyu Kim; Gijung Kwak; Ji Young Yhee; Ick-Chan Kwon; Sun Hwa Kim; Yoon Yeo
Journal:  ACS Biomater Sci Eng       Date:  2017-05-03

Review 6.  Polymeric drugs: Advances in the development of pharmacologically active polymers.

Authors:  Jing Li; Fei Yu; Yi Chen; David Oupický
Journal:  J Control Release       Date:  2015-09-26       Impact factor: 9.776

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.